Association of preoperative cone biopsy with recurrences after radical hysterectomy

Arch Gynecol Obstet. 2022 Jan;305(1):215-222. doi: 10.1007/s00404-021-06145-0. Epub 2021 Jul 21.

Abstract

Objective: To evaluate association of preoperative cone biopsy with the probability of recurrent disease after radical hysterectomy for cervical cancer.

Methods: This is a retrospective single-center study. Patients with cervical cancer stage IA1 with LVSI to IIA2 and squamous, adenosquamous and adenocarcinoma subtype were included. Patients were analyzed for general characteristics and recurrence-free survival (RFS).

Results: In total, of 480 patients with cervical cancer, 183 patients met the inclusion criteria (117 with laparoscopic and 66 with open surgery). The median tumor diameter was 25.0 mm (range 4.6-70.0 mm) with 66 (36.2%) patients having tumors smaller than 2 cm. During median follow-up of 54.0 months (range 0-166.0 months), the RFS for the laparoscopic cohort was 93.2% and 87.5% at 3 and 4.5 years, and 79.3% for the open cohort after 3 and 4.5 years, respectively. In total, 17 (9.3%) patients developed recurrent disease, 9 (7.3%) after laparoscopic, and 8 (12.1%) after open surgery. No preoperative cone biopsy (OR 9.60, 95% CI 2.14-43.09) as well as tumor diameter > 2 cm (OR 5.39, 95% CI 1.20-24.25) were significantly associated with increased risk for recurrence. In multivariate analysis, only missing preoperative cone biopsy was significantly associated with increased risk for recurrence (OR 5.90, 95% CI 1.11-31.29) CONCLUSION: There appears to be a subgroup of patients (preoperative cone biopsy, tumor diameter < 2 cm) with excellent survival and low risk for recurrence after radical hysterectomy which might benefit from the advantages of laparoscopic surgery.

Keywords: Cervical cancer; Cone biopsy; Laparoscopy; Radical hysterectomy; Recurrence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Conization
  • Disease-Free Survival
  • Female
  • Humans
  • Hysterectomy / adverse effects
  • Laparoscopy* / adverse effects
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Recurrence
  • Retrospective Studies
  • Uterine Cervical Neoplasms* / pathology